Operating for over 40 years, the Cork site is proud to manufacture and supply Active Pharmaceutical Ingredients (API) to our customers for use in clinical trials and approved medicines for commercial supply - medicines to treat Cancer, Parkinson’s Disease, Depression, HIV, Congestive Heart Failure, Diabetes and Respiratory diseases, along with raw material for consumer healthcare products.
What makes the site great is the technical capability and scientific expertise of our team and our state-of-the-art laboratories and production facilities. The site specialises in new product introduction, scale-Up, commercialisation and process optimisation.
There are 500+ people employed at the Cork site – a team of dedicated and highly qualified chemists, engineers, analysts, operators and crafts personnel. Putting patients at the heart of what we do, our team is focused on ‘right first time’, and quality and safety at all times.
The Cork team also has an excellent Environment Health and Safety and sustainability track record, with best-in-class environmental facilities and energy and waste reduction programmes.
The Cork site is welcoming exciting growth and new expansions to support much-needed capacity for APIs currently in development and the increasing needs of customers and the patients we serve.
What makes the site great is the technical capability and scientific expertise of our team and our state-of-the-art laboratories and production facilities. The site specialises in new product introduction, scale-Up, commercialisation and process optimisation.
There are 500+ people employed at the Cork site – a team of dedicated and highly qualified chemists, engineers, analysts, operators and crafts personnel. Putting patients at the heart of what we do, our team is focused on ‘right first time’, and quality and safety at all times.
The Cork team also has an excellent Environment Health and Safety and sustainability track record, with best-in-class environmental facilities and energy and waste reduction programmes.
The Cork site is welcoming exciting growth and new expansions to support much-needed capacity for APIs currently in development and the increasing needs of customers and the patients we serve.